Expression levels of ROS1/ALK/c-MET and therapeutic efficacy of cetuximab plus chemotherapy in advanced biliary tract cancer

Aberrant expression of ROS1, ALK or c-MET (RAM) is implicated in carcinogenesis and cancer drug resistance. We retrospectively evaluated the effect of RAM expression on outcomes for advanced biliary tract cancer patients, who were treated with gemcitabine plus oxaliplatin (GEMOX), with or without ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Nai-Jung, Hsu, Chiun, Chen, Jen-Shi, Tsou, Hsiao-Hui, Shen, Ying-Ying, Chao, Yee, Chen, Ming-Huang, Yeh, Ta-Sen, Shan, Yan-Shen, Huang, Shiu-Feng, Chen, Li-Tzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853728/
https://www.ncbi.nlm.nih.gov/pubmed/27136744
http://dx.doi.org/10.1038/srep25369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853728/
https://www.ncbi.nlm.nih.gov/pubmed/27136744
http://dx.doi.org/10.1038/srep25369

Ejemplares similares